Evaluation of Lymphodepletion With ALLO-647 in Adults With R/R Large B Cell Lymphoma Receiving ALLO-501A Allogeneic CAR T Cell Therapy
Clinical trial NCT05714345 · TERMINATED
Trial details
- NCT number
- NCT05714345
- Sponsor
- Allogene Therapeutics
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-11-01
- Primary completion
- 2024-02-20
- Enrollment
- 2
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.